Clinical trial
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent With Neurotrophic Properties in Major Depression
NCT00026052 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent With Neurotrophic Properties in Major Depression
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2001
- Completion date
- April 30, 2003
- Enrollment
- 31
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression